-
Featured
HIV Positive Patients at Higher Risk of VTE After TJA
Jeffrey J. Olson, MD, and Hany S. Bedair, MD, of the Department of Orthopaedic Surgery, and colleagues found that the odds of venous thromboembolism after total hip or knee replacement were 11 times higher in HIV-positive patients than in matched HIV-negative controls.
-
CNS Cells Can Be Reservoirs for Long-term HIV-1 Persistence Despite Antiretroviral Therapy
In autopsy samples from people treated with antiretroviral therapy, Massachusetts General Hospital researchers found intact HIV-1 proviruses in the central nervous system and other organs, and they showed brain tissue can be involved in multi-compartment dissemination of large clones of HIV-1 proviruses.
-
Older Ugandans With Treated HIV Report Better QoL Than Ugandans Without HIV
Lien T. Quach, PhD, Mark J. Siedner, MD, MPH, and colleagues found that in several respects, older Ugandans with HIV have better health-related quality of life than sex- and age-similar people without HIV, perhaps because of the primary health care and other support often offered to people with HIV in the global south.
-
Diet Quality Is Suboptimal or Poor in Large Proportion of Global Population With HIV
Kathleen V. Fitch, MSN, a principal associate in medicine at Massachusetts General Hospital, Steven K. Grinspoon, MD, chief of the Metabolism Unit, and colleagues conducted the first analysis of diet in a global cohort of people with HIV infection and found diet quality was poor or suboptimal in 42% of individuals.
-
Monitoring Novel HBV Markers Worthwhile in HBeAg-positive Patients Coinfected With HIV
In a longitudinal study, Raymond T. Chung, MD, and colleagues in the Hepatitis B (HBV) Research Network demonstrated a clear relationship between the novel biomarkers HBV RNA and HBcrAg—and by inference HBV transcription status—in HBeAg-positive but not HBeAg-negative patients with HBV–HIV coinfection.
-
Preventing Heart Disease After HIV Infection
Research at Massachusetts General Hospital has led to several landmark studies, including the REPRIEVE trial, aimed at understanding and preventing HIV-related heart disease.
HIV Contributors
-
Hany S. Bedair, MD
Chief, Center for Hip & Knee Replacement, Department of Orthopaedic Surgery, Massachusetts General Hospital, Director, MGH/NWH Kaplan Joint Center at NWH, Associate Professor of Orthopaedic Surgery, Harvard Medical School
Recent Article
Clinical Outcomes Are Comparable With Robotic and Manual Total Hip Arthroplasty
-
Kathleen E. Corey, MD, MPH, MMSc
Director, Fatty Liver Clinic, Mass General Gastrointestinal Unit, Associate Professor of Medicine, Harvard Medical School
Recent Article
Tobacco Use and Type 2 Diabetes Have Additive Effect on Risk of Fibrosis in Patients With MASLD
-
Raymond T. Chung, MD
Vice Chief, Division of Gastroenterology, Director, Hepatology and Liver Center, Massachusetts General Hospital
Recent Article
Monitoring Novel HBV Markers Worthwhile in HBeAg-positive Patients Coinfected With HIV
-
Shibani S. Mukerji, MD, PhD
Assistant Professor of Neurology, Associate Director of the Neuro-infectious Diseases Unit
Recent Article
CNS Cells Can Be Reservoirs for Long-term HIV-1 Persistence Despite Antiretroviral Therapy
-
Steven Kyle Grinspoon, MD
Chief, Metabolism Unit, Massachusetts General Hospital, Director, Nutrition Obesity Research Center, Harvard
Recent Article
Diet Quality Is Suboptimal or Poor in Large Proportion of Global Population With HIV
-
Tomas G. Neilan, MD, MPH
Director, Cardio-Oncology Program, Massachusetts General Hospital, Co-Director, Cardiac MR PET CT Program
Recent Article
T1 Value on Cardiac MRI Diagnoses Myocarditis Associated with Checkpoint Inhibitors
